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ABSTRACT: Introduction: Foot deformities are frequent compli-
cations in Charcot–Marie–Tooth disease (CMT) patients, often
requiring orthopedic surgery. However, there are no prospec-
tive, randomized studies on surgical management, and there is
variation in the approaches among centers both within and
between countries. Methods: In this study we assessed the fre-
quency of foot deformities and surgery among patients recruited
into the Inherited Neuropathies Consortium (INC). We also
designed a survey addressed to orthopedic surgeons at INC
centers to determine whether surgical approaches to orthopedic
complications in CMT are variable. Results: Foot deformities
were reported in 71% of CMT patients; 30% of the patients had
surgery. Survey questions were answered by 16 surgeons work-
ing in different specialized centers. Most of the respondents
were foot and ankle surgeons. There was marked variation in
surgical management. Discussion: Our findings confirm that the
approaches to orthopedic management of CMT are varied. We
identify areas that require further research.
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Charcot–Marie–Tooth disease (CMT) is the most
common inherited peripheral neuropathy.1 Clini-
cally, it is characterized by slowly progressive distal
wasting, weakness, and sensory loss affecting the
lower and upper limbs. Foot deformities, namely
forefoot cavus, clawtoes, hindfoot varus, and ankle
instability, are frequently observed and are a major
source of the disability associated with CMT and
commonly result in patients being referred for
orthopedic surgery. Muscular imbalance between
the weaker tibialis anterior overpowered by the
stronger peroneus longus muscles and weakness of
intrinsic foot muscles have been suggested as the
main causes of forefoot cavus in CMT.2,3 Orthope-
dic surgery is frequently required for CMT patients
to correct severe foot deformities. The goals of sur-
gical intervention for patients with CMT are to
obtain a plantigrade foot and to correct the bony
deformities and muscle imbalance. The indication
for surgery is usually determined by failure of con-
servative measures, such as physical therapy and
use of orthoses, which are first-line treatments for
foot deformities in CMT. Several procedures have
been described in isolation and in combination for
the correction of foot deformities. These include
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soft tissue procedures, such as plantar fascia
release, tendon transfers, and tendon lengthening,
which are usually performed for mild flexible
deformities. Corrective osteotomies, such as calca-
neal osteotomy and first metatarsal osteotomy, may
be performed when greater deformity correction is
needed or when the deformity has become rigid.
Fusion procedures, such as triple arthrodesis, are
usually reserved for when there are severe degener-
ative joint changes and deformities.4–6 No single
surgical procedure can achieve all these goals
simultaneously, and surgical decisions are usually
individualized.7 The long-term results of surgical
procedures on foot deformities in CMT patients
have been addressed in just a few studies,5,6 so evi-
dence regarding optimal surgical management for
these patients is lacking. Furthermore, we have
observed that current approaches appear to vary
between centers in the same country and between
different countries. The aims of this study were to
determine: (1) the frequency of foot deformities
in CMT and the proportion of patients undergo-
ing foot surgery; and (2) whether current surgical
approaches to the management of orthopedic
complications in CMT are variable, even in special-
ized centers.
METHODS
The study was conducted by the Inherited Neuropathies
Consortium (INC), a member of the Rare Diseases Clinical
Research Network (RDCRN). The INC is an international
consortium performing clinical research and natural history
studies in CMT. Ethics approval was obtained by the insti-
tutional review board (IRB) at all participating institutions
and written informed consent was obtained from all
participants.
INC Patient Foot Deformity Data. Data from patients
recruited in the INC Natural History Study of CMT and
Related Inherited Neuropathies were interrogated to collect
details on diagnosis, presence of foot deformities (pes cavus,
hammer toes, pes planus), use of orthotic aids (shoe inserts,
ankle foot orthosis), and details of foot surgery (tendon
transfer, Achilles tendon lengthening, ankle joint fusion,
osteotomy, toe straightening). These data were collected as
part of a minimal data set completed by a clinician during
assessment for the Natural History Study.8
Survey of Orthopedic Surgeons. A survey was designed
by an experienced foot and ankle orthopedic surgeon
(D.S.), who specializes in surgery for CMT, and consisted of
6 questions (refer to Supplementary Material, available
online). The survey was aimed at experienced CMT ortho-
pedic surgeons and included questions regarding the type
of orthopedic practice, number of referrals of patients with
severe pes cavus received per year, number of CMT patients
seen per year, number of corrections of severe pes cavus
performed per year, and number of CMT patients with flat
feet encountered. The survey included 2 clinical scenarios
of typical CMT patients: a 13-year-old and a 24-year-old
CMT patient with typical pes cavus who had failed conserva-
tive measures. The orthopedic surgeons were asked what
procedures they would commonly carry out in the scenario
by selecting 1 or more of 12 options.
Study Participants. The survey was limited to surgeons
performing surgical procedures for foot deformities in CMT
patients who were attending centers participating in the
INC. Orthopedic surgeons were identified and contacted by
investigators belonging to the INC and asked to complete
the survey.
Statistical Analysis. Median and range (minimum and
maximum) were calculated for age of patients who under-
went surgery. Frequency of foot deformities, use of orthotic
aids, type of surgery, and number of patients who did not
undergo surgery were expressed as a percentage. The chi-
square test was performed to compare patients with a diag-
nosis of CMT with other subtypes [hereditary sensory neu-
ropathy (HSN), hereditary motor neuropathy (HMN), and
hereditary neuropathy with liability to pressure palsies
(HNPP)]. The non-parametric Spearman test was per-
formed to assess the correlation between number of inter-
ventions per year performed by individual surgeons and
number of procedures suggested in response to clinical
scenarios.
RESULTS
Patients’ Details. Baseline data were obtained
from 2,706 patients recruited between August 2009
and December 2014. Results are summarized in
Table 1. There were 1,953 patients with a diagnosis
of CMT, 72 with HMN, 65 with HSN, and 49 with
HNPP. The precise diagnosis was not included for
567 patients entered in the natural history study.
Patients’ median age was 40 years, and ranged
between 1 and 93 (interquartile range 19–55)
years. Foot deformities were reported in 1,522 of
2,139 patients (71%) with a diagnosis of CMT and
related inherited neuropathies (HNPP, HMN, and
HSN) and were more common in patients with a
diagnosis of CMT (1,443 of 1,953, 74%) (Table 1)
compared with other subtypes (HMN, HSN, and
HNPP; 79 of 186, 42%). Pes cavus and hammer
toes were more commonly reported than pes pla-
nus in patients with CMT. Pes cavus was reported
in 63% of patients with CMT1A. Shoe inserts and
ankle-foot orthoses were used, respectively, by 357
of 1,443 (25%) and 509 of 1,443 (35%) of CMT
patients with foot deformities, by 13 of 39 (33%)
and 16 of 39 (41%) of dHMN patients with foot
deformities, by 8 of 24 (33%) and 7 of 24 (29%)
of HSN patients with foot deformities, and by 2 of
16 (12%) and 4 of 16 (25%) of HNPP patients
with foot deformities.
Overall, 30% of patients underwent foot sur-
gery for correction of foot deformities; of these,
420 of 574 (73%) had a diagnosis of CMT and 205
of 420 (49%) had a diagnosis of CMT1A. Further-
more, 407 of 1,390 (29%) of the patients with pes
cavus, 253 of 694 (36%) of the patients with ham-
mer toes and 48 of 215 (22%) of the patients with
pes planus had surgery. The ages of those who
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underwent surgery were available for 68% of the
patients. Median age for any type of surgery was 15
(range 1-73) years, with median ages for specific
surgeries as follows: tendon transfer 16 (range 0.8–
66) years; Achilles tendon lengthening 13 (range
0.8–73) years; osteotomy 17 (range 3–66) years; toe
straightening 22 (range 9–66) years; and ankle
arthrodesis 18 (range 8–64) years. Furthermore,
128 of 389 (33%) patients had surgery more than
once and the median interval between first and
last surgery was 5 (range 1–58) years. The surgical
procedures performed are summarized in Table 1.
Survey. Sixteen orthopedic surgeons working in
selected INC CMT-specialized centers worldwide
were surveyed. Three surgeons were based in the
UK, 2 in Italy, 3 in Australia, and 8 in the USA.
Eight (50%) were pediatric orthopedic surgeons, 4
(25%) were adult foot and ankle orthopedic sur-
geons, 3 (19%) were both adult foot and ankle
and pediatric orthopedic surgeons, and only 1
(6%) was a general orthopedic surgeon with an
interest in foot and ankle and pediatric surgery.
Five (31%) surgeons received> 15 referrals of pa-
tients with severe pes cavus per year and assessed
>15 CMT patients per year, whereas the remainder
received between 2 and 10 referrals per year. Six
(37%) performed between 6 and 10 corrections
per year for severe pes cavus.
For both clinical scenarios, a variety of combi-
nations of procedures commonly performed to
correct pes cavus were selected by the surgeons.
The median number of procedures per surgery
was 5 (range 1–12) for the pediatric scenario and
6 (range 1–8) for the adult scenario. The most
common procedures for the pediatric clinical sce-
nario were calcaneal osteotomy and peroneal ten-
don transfer (both 12 of 16) and first metatarsal
osteotomy and plantar fascia release (both 11 of
16) (Fig. 1). For the adult clinical scenario, 13 of
14 surgeons (93%) would commonly perform cal-
caneal osteotomy, 11 of 14 (78%) would com-
monly perform first metatarsal osteotomy or
plantar fascia release, and 10 of 14 (71%) would
perform peroneal tendon transfer (Fig. 2). Mid-
foot osteotomy, triple arthrodesis, and midfoot
fusion were rarely selected in either scenario.
Overall, in both scenarios, the majority of sur-
geons (10 of 16) would perform at least calcaneal
osteotomy and peroneal tendon transfer as part of
the procedure to correct pes cavus. However, the
exact combination varied considerably among sur-
geons, with only 2 surgeons selecting a similar
combination of procedures to correct pes cavus on
a pediatric case (calcaneal osteotomy, peroneal
tendon transfer, first metatarsal osteotomy, and
plantar fascia release) and none of the surgeons
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selecting an identical combination of procedures
for an adult case. There was no correlation bet-
ween numbers of interventions per year performed
by individual surgeons and numbers of procedures
suggested in response to clinical scenarios. There
were no differences in terms of answers between
surgeons from the USA and surgeons from the
UK, Australia, and Italy.
DISCUSSION
Our analysis of data collected from the large
cohort of patients enrolled in an international nat-
ural history study showed that foot deformities
were reported in 1,914 of 2,706 patients (71%)
with CMT and related disorders, and 30% of
patients required surgery for correction of foot
deformities. Interestingly, 63% of patients with pes
cavus had a diagnosis of CMT1A genetically con-
firmed, whereas pes cavus was less frequently
observed in other subtypes of inherited neuropa-
thy. These data confirm previous studies in which
the presence of pes cavus ranged between 40%
and 77% in CMT1A patients,9–12 suggesting the
role of muscular imbalance between anterolateral
and posteromedial compartments in the
pathogenesis of pes cavus.12 The relatively rarer
presence of foot deformities in other subtypes of
CMT, such as in HMN, could be explained by the
differing muscular involvement with both anterior
and posterior compartment muscles affected.
These observations may be relevant for the man-
agement of orthopedic complications in CMT
patients. Furthermore, in the present cohort, the
use of orthoses (ankle-foot orthosis and shoe
inserts) was reported in 25%–41% of patients with
CMT and related neuropathies and foot deformi-
ties. However, we did not study correlations
between conservative measures and either need for
orthopedic interventions or outcome of surgical
interventions as these were outside the scope of
this study.
Our survey, although limited by the small num-
ber of participating surgeons, highlights the vari-
ability of the surgical approach to management of
orthopedic complications in CMT, even among
centers with specific expertise in CMT. The cohort
interviewed included both pediatric and adult sur-
geons who regularly operate on foot deformities in
CMT patients. Interestingly, the approach to ortho-
pedic management of patients with CMT varied
FIGURE 2. Adult clinical scenario. Each column5 surgical pro-
cedures; Each row represents the procedures chosen by each
surgeon; Right hand column5 total number of procedures sug-
gested by each surgeon; bottom row5 total number of times
each procedure was chosen amongst surgeon responders.
FIGURE 1. Paediatric clinical scenario. Each column5 surgical
procedures; Each row represents the procedures chosen by
each surgeon; Right hand column5 total number of procedures
suggested by each surgeon; bottom row5 total number of times
each procedure was chosen amongst surgeon responders.
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considerably among surgeons, with only 2 surgeons
agreeing on a similar combination of procedures
in a pediatric case and none of the surgeons per-
forming a similar combination of procedures in an
adult case. These findings confirm the perception
that surgical approach varies between different
centers and between different countries. There-
fore, both developing guidelines and identifying
areas for research in surgery for CMT are very
important.
It is noteworthy that the majority of the surgeons
would perform at least calcaneal osteotomy and
peroneal tendon transfer as part of procedures
undertaken in both scenarios to correct pes cavus.
The primary deformity in CMT is thought to be
imbalance of the intrinsic foot muscles and/or an
imbalance between tibialis anterior and peroneus
longus giving rise to a plantarflexed first metatarsal
and a pronated foot. The hindfoot varus is thought
to be secondary—initially correctable, but becoming
fixed with time. There was substantial disagreement
on the role of metatarsal osteotomy in correcting
deformity, with 11 of 14 surgeons performing meta-
tarsal dorsiflexion osteotomy in the adult case and 9
of 16 performing the Robert Jones soft-tissue proce-
dure in the pediatric case. Controversy exists in the
orthopedic literature as to whether the plantar fas-
cia is tight in pes cavus. This was confirmed in our
finding that 11 of 16 surgeons would perform a
plantar fascia release in a pediatric patient and 11 of
14 surgeons would do a plantar fascia release in an
adult patient. The use of various approaches among
surgeons reflects a lack of understanding of the
exact pathogenesis of foot deformities in CMT. It
may be that the pathogenic mechanism is different
in various types of CMT and further research is
needed.
In conclusion, the results of this study on both
the frequency of foot deformity in CMT and the
approach to treatment, despite the limitations dis-
cussed, highlight the need for further research
and the need for guidelines for foot surgery, which
should include indications for and timing of sur-
gery, type of surgery, and guidance for follow-up.
The development of guidelines will require careful
follow-up of patients who have had surgery to
determine the long-term outcomes for different
procedures and need to take into consideration
both medical and surgical perceived efficacy. We
plan to undertake a workshop to develop a strategy
for addressing these issues.
The authors acknowledge Professor Francesco Muntoni, Dubowitz
Neuromuscular Centre, Department of Neurology, UCL Institute
of Child Health & Great Ormond Street Hospital, London, UK,
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